XORTX Therapeutics Inc. submitted a 6-K filing to the SEC on December 31, 2025, confirming its status as a foreign private issuer and indicating it will file annual reports under Form 20-F. The filing includes a news release dated the same day.
AI Assistant
XORTX THERAPEUTICS INC
2026
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.